Latest Insider Transactions at Bei Gene, Ltd. (BGNE)
This section provides a real-time view of insider transactions for Bei Gene, Ltd. (BGNE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BeiGene, Ltd. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BeiGene, Ltd.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 09
2024
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,200
-7.86%
|
$1,713,600
$153.32 P/Share
|
|
Mar 13
2024
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,332
-54.32%
|
$2,207,428
$179.91 P/Share
|
|
Mar 12
2024
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
37,668
-19.26%
|
$6,215,220
$165.33 P/Share
|
|
Mar 11
2024
|
Donald W. Glazer Director |
SELL
Bona fide gift
|
Direct |
82,020
-2.95%
|
-
|
|
Feb 29
2024
|
Julia Aijun Wang Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
397
-100.0%
|
$66,299
$167.08 P/Share
|
|
Nov 30
2023
|
Xiaodong Wang Director |
SELL
Other acquisition or disposition
|
Indirect |
172,372
-100.0%
|
-
|
|
Nov 30
2023
|
Xiaodong Wang Director |
SELL
Bona fide gift
|
Direct |
71,890
-1.3%
|
-
|
|
Nov 14
2023
|
Baker Bros. Advisors LP |
SELL
Open market or private sale
|
Indirect |
1,100,000
-9.43%
|
$198,000,000
$180.5 P/Share
|
|
Jul 31
2023
|
Chan Henry Lee SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
791
-100.0%
|
$170,856
$216.26 P/Share
|
|
Jul 03
2023
|
Julia Aijun Wang Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
472
-100.0%
|
$84,488
$179.55 P/Share
|
|
Jun 26
2023
|
Xiaobin Wu President, COO & GM China |
SELL
Open market or private sale
|
Direct |
1,495
-100.0%
|
$272,090
$182.37 P/Share
|
|
Jun 26
2023
|
Lai Wang Global Head of R&D |
SELL
Open market or private sale
|
Direct |
1,108
-99.77%
|
$201,656
$182.53 P/Share
|
|
Jun 23
2023
|
Corazon (Corsee) D. Sanders Director |
SELL
Open market or private sale
|
Direct |
578
-58.65%
|
$104,618
$181.7 P/Share
|
|
Jun 23
2023
|
Julia Aijun Wang Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
840
-100.0%
|
$152,880
$182.85 P/Share
|
|
Jun 20
2023
|
Xiaobin Wu President, COO & GM China |
SELL
Open market or private sale
|
Direct |
1,753
-100.0%
|
$336,576
$192.44 P/Share
|
|
Jun 20
2023
|
Julia Aijun Wang Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
190
-100.0%
|
$36,480
$192.54 P/Share
|
|
Jun 20
2023
|
Lai Wang Global Head of R&D |
SELL
Open market or private sale
|
Direct |
1,325
-100.0%
|
$254,400
$192.42 P/Share
|
|
Jun 15
2023
|
John Oyler Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
355,641
+15.28%
|
-
|
|
Jun 15
2023
|
Xiaodong Wang Director |
BUY
Grant, award, or other acquisition
|
Direct |
86,216
+1.53%
|
-
|
|
Jun 15
2023
|
Xiaobin Wu President, COO & GM China |
BUY
Grant, award, or other acquisition
|
Direct |
200,447
+16.25%
|
-
|
|
Jun 15
2023
|
Julia Aijun Wang Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
107,770
+23.95%
|
-
|
|
Jun 15
2023
|
Margaret Dugan Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,922
+30.38%
|
-
|
|
Jun 15
2023
|
Corazon (Corsee) D. Sanders Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,922
+25.67%
|
-
|
|
Jun 15
2023
|
Thomas Malley Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,922
+21.67%
|
-
|
|
Jun 15
2023
|
Alessandro Riva Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,922
+30.38%
|
-
|
|
Jun 15
2023
|
Chan Henry Lee SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
65,585
+26.53%
|
-
|
|
Jun 15
2023
|
Donald W. Glazer Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,922
+0.46%
|
-
|
|
Jun 15
2023
|
Anthony C Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,922
+25.67%
|
-
|
|
Jun 15
2023
|
Lai Wang Global Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
133,627
+7.64%
|
-
|
|
Jun 15
2023
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
51,688
+21.67%
|
-
|
|
Jun 15
2023
|
Qingqing Yi Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,922
+30.38%
|
-
|
|
Jun 14
2023
|
Hhlr Advisors, Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
273,728
-0.19%
|
$56,661,696
$207.72 P/Share
|
|
Jun 13
2023
|
Hhlr Advisors, Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
924,400
-0.32%
|
$156,223,600
$169.94 P/Share
|
|
Jun 12
2023
|
Hhlr Advisors, Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,250,212
-0.43%
|
$215,036,464
$172.37 P/Share
|
|
Jun 09
2023
|
Hhlr Advisors, Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
542,652
-0.19%
|
$93,878,796
$173.69 P/Share
|
|
Jun 08
2023
|
Hhlr Advisors, Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,163,825
-0.79%
|
$253,713,850
$218.14 P/Share
|
|
Jun 07
2023
|
Xiaobin Wu President, COO & GM China |
SELL
Open market or private sale
|
Direct |
3,291
-51.65%
|
$737,184
$224.67 P/Share
|
|
Jun 07
2023
|
Lai Wang Global Head of R&D |
SELL
Open market or private sale
|
Direct |
462
-51.6%
|
$103,488
$224.67 P/Share
|
|
May 08
2023
|
Xiaobin Wu President, COO & GM China |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$1,771,000
$253.72 P/Share
|
|
Mar 16
2023
|
Xiaodong Wang Director |
SELL
Bona fide gift
|
Direct |
67,444
-1.22%
|
-
|
|
Mar 08
2023
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Direct |
67,635
-28.82%
|
$15,217,875
$225.59 P/Share
|
|
Mar 08
2023
|
Xiaodong Wang Director |
BUY
Exercise of conversion of derivative security
|
Direct |
67,635
+50.0%
|
$0
$0.13 P/Share
|
|
Mar 01
2023
|
Julia Aijun Wang Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
343
-100.0%
|
$82,320
$240.21 P/Share
|
|
Jan 12
2023
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Indirect |
5,000
-90.99%
|
$1,300,000
$260.9 P/Share
|
|
Jan 11
2023
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Direct |
2,500
-63.21%
|
$630,000
$252.55 P/Share
|
|
Jan 10
2023
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
13,594
-56.73%
|
$3,371,312
$248.72 P/Share
|
|
Jan 10
2023
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,797
-56.73%
|
$1,685,656
$248.72 P/Share
|
|
Jan 10
2023
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Direct |
1,600
-100.0%
|
$400,000
$250.09 P/Share
|
|
Jan 09
2023
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Direct |
900
-100.0%
|
$225,000
$250.0 P/Share
|
|
Dec 29
2022
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
3,434
-97.32%
|
$769,216
$224.78 P/Share
|